Font Size: a A A
Keyword [CYP2C9]
Result: 101 - 119 | Page: 6 of 6
101. Gene-Gene Interaction Analyses Among CYP2C9?HABP2?ABO And HDAC9 Genotypes For Stroke In Patients With Atrial Fibrillation
102. Association Of HLA-B*15:02 And CYP2C9*3 With Phenytoin-induced SJS/TEN: Systematic Review And Meta-analysis
103. CYP2C9 binding determinants and activation mechanisms for phenytoin and (S)-warfarin metabolism
104. Clinical utility, cost-effectiveness and provider perceptions of CYP2C9 and VKORC1 genotyping for chronic warfarin therapy
105. A study to investigate the mechanisms of Danshen-drug interactions using cytochrome P450 probe substrates
106. Structural determinants of CYP2C9's genetic variability, substrate specificity and dioxygen cleavage
107. Cost-Effectiveness of Current Anticoagulation Care versus Genetic Testing of CYP2C9 and VKORC1 Prior to Long-Term Warfarin Anticoagulation Care: The Implementation of Discrete Event Simulation Model on the Natural History of Venous Thromboembolism
108. Development of an Allele Specific PCR Method for the Genotyping of CYP2C9 Mutations Isolated from Oral Fluid Samples
109. Anti-salmonella adhesion activity of Saccharomyces boulardii: Effects of Ginkgo biloba on activities of cytochromes P-450
110. Microbial transformations of the antimelanoma agent betulinic acid
111. Analytical and Computational Methods for the Assessment of Biological Molecules and their Binding Interactions: Case Studies in DNA Aptamer-Target Binding and P450-P450 Dimerization
112. The Clinical Study Of Warfarin Precious Anticoagulant Therapy With Clinical Parmacists Participation
113. Study On The Drug Metabolic Properties Of Cytochrome P450 2C9 R150H And R150L Variants
114. To Establish The Individual Warfarin Application Model Of Chinese Han Population Based On Gene Polymorphism And Discuss The Relationship Between The Risk Of Bleeding And Gene Polymorphism
115. Identification And Functional Characterization Of A New CYP2C9 Variant CYP2C9*62 And The Drug Metabolic Activity Analysis Of The Defective CYP2C9 Variant CYP2C9*18
116. Effects Of CYP2C9 Single Nucleotide Polymorphism On The Safety Of Silybin Combined With Phenytoin
117. Evaluation Of The Accuracy Of Different Gene-guided Drug Delivery Models In Predicting Warfarin Dose In Yunnan Population
118. Effect Of Cytochrome P-450 2C9 Gene Polymorphism On Steady-state Warfarin Dose In Patients With Atrial Fibrillation
119. Effects Of Polygonum Multiflorum On Human Hepatocyte P450 Enzyme MRNA Expression And Cell Viability Under CYP2E1 Inhibition
  <<First  <Prev  Next>  Last>>  Jump to